Indeed, the temporal and spatial control of CAR transcription in tumours remains poorly understood, but reports highlight transforming growth factor-β (TGFβ), ZEB1 and the transcription factor Sp-1 as potential regulators of expression levels in cancer [52–54]. Here, CXADR is linked to cancer.